NCT07036575 Easy-to-Read Content Effectiveness Evaluation
| NCT ID | NCT07036575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Health Knowledge |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-06 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2025-06 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Individuals with intellectual disabilities face challenges in accessing medical services and health education due to communication barriers and limited support tools. Traditional information delivery methods often fail to meet their needs, leading to unequal access to preventive care and early screening. This integrated program aims to promote visual health among individuals with intellectual disabilities through the development and implementation of inclusive technologies. The program consists of three sub-projects: 1. Visual Health Promotion and Development of an Inclusive Information Platform for Individuals with Intellectual Disabilities - developing accessible health materials for individuals with intellectual disabilities and their families. 2. Development and Promotion of a Digital Visual Health Screening System for Individuals with Intellectual Disabilities - designed to support early detection and intervention tailored to this population. 3. Development of a Healthcare Access Platform and Assistive Technologies for Individuals with Intellectual Disabilities - reducing communication barriers during medical visits through technological support. Previously, our team developed and tested easy-to-read (ETR) materials with adults with intellectual disabilities, focusing on medical visits, eye diseases, and eye care. Once validated, these materials are planned to be adapted into digital versions and serve as the foundation for an online platform. To evaluate the effectiveness of ETR content, we will conduct an experimental study with 250 children and adolescents with special needs from across Taipei and New Taipei City in Taiwan. Participants will receive different types of visual health education, and outcomes will be measured by improvements in their knowledge. This study aims to validate the impact of ETR resources in reducing health information inequality and improving visual health awareness in this underserved population.
Eligibility Criteria
Inclusion Criteria: * Children and adolescents aged 3 to under 18 * Children and adolescents with intellectual disabilities and developmental delays. * Children and adolescents who are able to correctly identify at least two out of the three images in the pre-assessment phase. Exclusion Criteria: * Severe cognitive impairments, hearing impairments, speech disorders, or motor disabilities that would interfere with assessment procedures or participation in the instructional activities.
Contact & Investigator
Li-Ting Tsai
STUDY CHAIR
National Taiwan University
Frequently Asked Questions
Who can join the NCT07036575 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 17 Years, studying Health Knowledge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07036575 currently recruiting?
Yes, NCT07036575 is actively recruiting participants. Contact the research team at litingtsai@ntu.edu.tw for enrollment information.
Where is the NCT07036575 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07036575 clinical trial?
NCT07036575 is sponsored by National Taiwan University Hospital. The principal investigator is Li-Ting Tsai at National Taiwan University. The trial plans to enroll 250 participants.